Bone health has become an increasingly important consideration in the management of oestrogen receptor-positive early breast cancer. A position statement summary, published in the MJA, has emphasised the need for bone health to be taken into account in the decision-making process regarding initial choice and duration of endocrine therapy. As well, bone health should be assessed ...
Bone loss an important consideration in endocrine therapy for breast cancer.
By Mardi Chapman
31 Jul 2019